Famotidine Dosing for a 4-Year-Old Child Weighing 35 lb (16 kg)
For a 4-year-old child weighing 35 lb (approximately 16 kg), the appropriate famotidine dose using a 40 mg/5 mL suspension is 0.5 mg/kg, which equals 8 mg per dose, administered as 1 mL of the suspension.
Weight-Based Dosing Calculation
- Standard pediatric dosing for famotidine is 0.5 mg/kg per dose for children, based on pharmacodynamic studies showing similar gastric acid suppression relationships between pediatric patients and adults 1
- For a 16 kg child: 0.5 mg/kg × 16 kg = 8 mg per dose 1
- Using the 40 mg/5 mL concentration: (8 mg ÷ 40 mg) × 5 mL = 1 mL per dose 1
Dosing Frequency and Duration
- Administer twice daily (morning and evening) for most acid-related conditions 2, 3
- For maintenance therapy or less severe conditions, once-daily evening dosing may be appropriate 2, 4
- Treatment duration typically ranges from 4 to 8 weeks for peptic ulcer disease, with endoscopic reassessment at 4 weeks 4
Pharmacokinetic Considerations in Pediatric Patients
- Pediatric patients aged 11-15 years receiving 0.5 mg/kg maintained gastric pH above 5 for 13.5 ± 1.8 hours, demonstrating adequate acid suppression 1
- Oral bioavailability in pediatric patients (0.5) is comparable to adults (0.42-0.49), supporting weight-based dosing extrapolation 1
- Peak plasma levels occur in 1-3 hours after oral administration, with effects beginning within 1 hour 5
Administration Guidelines
- May be given with or without food, though administration with meals may slightly increase bioavailability and improve tolerability 1, 5
- The oral suspension should be shaken well before each dose
- Use an accurate measuring device (oral syringe preferred) rather than household spoons for the 1 mL dose
Safety and Monitoring
- Famotidine is well tolerated in pediatric populations with minimal adverse effects 2, 6
- No routine laboratory monitoring is required for children with normal renal function 6
- Unlike cimetidine, famotidine does not interact with cytochrome P-450 enzymes and has no clinically significant drug interactions 5, 6
- No antiandrogenic effects have been reported, distinguishing it from cimetidine 2, 6
Critical Caveats
- Renal impairment: If creatinine clearance is reduced, dose adjustment may be necessary, as famotidine is 65-70% renally eliminated 1, 5
- Duration of therapy: Extending treatment beyond 12 weeks without endoscopic reassessment is not recommended for erosive conditions 3
- Symptom relief typically occurs before complete healing; continued treatment for the full prescribed course is essential even after symptoms resolve 4, 3